You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,099 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-19
Jan 19, 2022
M
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-29
Dec 29, 2021
G
Completed
  • Philadelphia Positive Acute Lymphoblastic Leukemia
  • Stuttgart, Baden-Württemberg, Germany
  • +21 more
2022-01-10
Jan 10, 2022
U
Recruiting
  • Acute Lymphoblastic Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
2022-02-08
Feb 8, 2022
U
Active, not recruiting
  • CML, Chronic Phase
  • +4 more
  • Chapel Hill, North Carolina
    UNC Hospital
2021-08-27
Aug 27, 2021
O
Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Recurrent B Acute Lymphoblastic Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
2021-12-27
Dec 27, 2021
M
Recruiting
  • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-01
Feb 1, 2022
M
Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
2021-12-27
Dec 27, 2021
B
Recruiting
  • Adult B Acute Lymphoblastic Leukemia
  • Philadelphia Chromosome Positive
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2021-10-11
Oct 11, 2021
M
Recruiting
  • Adult Acute Lymphoblastic Leukemia in Complete Remission
  • +3 more
  • Blinatumomab
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
2021-09-22
Sep 22, 2021
H
Completed
  • Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
  • Cairo, Egypt
    National Cancer Institute (NCI)
2021-02-22
Feb 22, 2021
M
Recruiting
  • Acute Lymphoblastic Leukemia
  • Philadelphia Chromosome-Positive
  • Blinatumomab
  • +3 more
  • New York, New York
  • +1 more
2021-12-01
Dec 1, 2021
M
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-20
Jan 20, 2022
M
Recruiting
  • Blasts 5 Percent or More of Bone Marrow Nucleated Cells
  • +4 more
  • ADCT-602
  • Monrovia, California
  • +1 more
2022-01-25
Jan 25, 2022
C
Recruiting
  • CD19 Positive
  • +3 more
  • Blinatumomab
  • +2 more
  • Duarte, California
    City of Hope Medical Center
2021-05-17
May 17, 2021
M
Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-05
May 5, 2021
I
Active, not recruiting
  • Acute,Leukemia, Lymphoid
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
2021-02-08
Feb 8, 2021
N
Completed
  • Philadelphia Positive Chronic Myeloid Leukemia
  • +2 more
  • STI571 400 mg
  • STI571 600 mg
  • Boston, Massachusetts
  • +11 more
2021-07-01
Jul 1, 2021
M
Active, not recruiting
  • Myeloproliferative Disorders
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-17
Nov 17, 2021
M
Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-25
Mar 25, 2022